Index of /pdf/
Name
Last Modified
Size
Parent Directory
01-immunotherapy-and-glioblastoma-multiforme.pdf
2019-05-07 07:35
360k
02-immunotherapy-and-hepatocellular-carcinoma.pdf
2019-05-07 07:35
357k
03-immunotherapy-and-gastroenteropancreatic.pdf
2019-05-07 07:35
409k
04-immunotherapy-and-malignant-pleural-mesothelioma.pdf
2019-05-07 07:35
380k
05-immunotherapy-and-pancreatic-cancer.pdf
2019-05-07 07:35
196k
06-immunotherapy-and-meningioma.pdf
2019-05-07 07:35
408k
07-immunotherapy-and-penis-cancer.pdf
2019-05-07 07:35
489k
08-Competitive-Treatment-in-Diffuse-Large .pdf
2019-05-07 07:35
274k
09-Frontline-Treatment-in-Diffuse-Large.pdf
2019-05-07 07:35
424k
10-malignant-melanoma.pdf
2019-05-07 07:35
144k
11-Gastrointestinal-Events-Associated-with.pdf
2019-05-07 07:35
343k
12-proteasome-inhibition-in-lymphoproliferative-disorder.pdf
2019-05-07 07:35
718k
13-toxicities-associated-with-antibody-drug-conjugates.pdf
2019-05-07 07:35
449k
14-mechanisms-of-drug-resistance-in-glioblastoma-multiforme.pdf
2019-05-07 07:35
252k
15-a-review-on-clinicopathological-correlation-between-classical.pdf
2019-05-07 07:35
644k
16-A-Review-on-Clinicopathological-Correlation-between.pdf
2019-05-07 07:35
644k
17-Safety-and-Efficacy-of-Peptide-Based-Vaccines.pdf
2019-05-07 07:35
455k
18-role-of-vascular-endothelial-growth-factor-receptor.pdf
2019-05-07 07:35
360k
19-immunotherapy-in-metastatic-renal-cell-carcinoma.pdf
2019-05-07 07:35
355k
20-anti-inflammatory-agents-and-their-role-in-atherosclerosis.pdf
2019-05-07 07:35
688k
21-complementary-medicines-and-cancer.pdf
2019-05-07 07:35
494k
22-complementary-medicines-and-cancer.pdf
2019-05-07 07:35
423k
23-a-review-article-on-emerging-role-of-hybrid-molecules.pdf
2019-05-07 07:35
190k
24-a-review-on-role-of-peptide-vaccines-in-cancer-therapy-treatment.pdf
2019-05-07 07:35
268k
25-growth-factor-as-a-supportive-treatment-in-chemotherapy.pdf
2019-05-07 07:35
349k
26-principles-of-nutritional-support-in-cancer-patients.pdf
2019-05-07 07:35
379k
27-a-review-article-on-neuropathic-pain.pdf
2019-05-07 07:35
474k
28-a-review-article-on-clinical-trials-on-hybrid-drugs-and-nanohybrid.pdf
2019-05-07 07:35
358k
29-management-of-neurological-adverse-events-associated.pdf
2019-05-07 07:35
410k
30-cox-2-inhibitors-and-their-role-in-cancer.pdf
2019-05-07 07:35
446k
31-cancer-related-fatigue-and-its-management.pdf
2019-05-07 07:35
815k
32-Gastrointestinal-Events-Associated-with-Ipilimumab.pdf
2019-05-07 07:35
343k
33-role-of-immunotherapy-for-h-pylori-in-gastric-cancer.pdf
2019-05-07 07:35
427k
34-immunotherapeutic-approach-to-squamous-cell-carcinoma-of-the-head-and-neck...
2019-05-07 07:35
345k
35-new-targets-in-treatment-of-myelodysplastic-syndrome.pdf
2019-05-07 07:35
342k
36-targeted-therapy-for-chondrosarcoma.pdf
2019-05-07 07:35
313k
37-therapeutic-approach-to-chordomas.pdf
2019-05-07 07:35
282k
38-novel-targets-and-breast-cancer-treatment.pdf
2019-05-07 07:35
480k
39-Novel-Approaches-In-Treatment-Of-Adult-AML.pdf
2019-05-07 07:35
503k
40-Emerging-Role-Of-Immunotherapy-In-Breast-Cancer.pdf
2019-05-07 07:35
516k
41-immunotherapeutic-approach-to-osteosarcoma.pdf
2019-05-07 07:35
575k
42-immunotherapeutic-approach-to-anal-cancer.pdf
2019-05-07 07:35
420k
43-Therapeutic-approach-to-CML-in-TKI-era.pdf
2019-05-08 03:36
229k
44-Immunotherapy-and-Cervical-Cancer.pdf
2019-05-08 03:36
533k
45-HIV-aND-HTLV1-ASSOCIATED-LYMPHOMA-IMMUNOTHERAPY.pdf
2019-05-08 03:36
638k
46-Immunotherapy-and-colon-cancer.pdf
2019-05-08 03:36
257k
47-Immunotherapy-in-Hodgkin-Lymphoma.pdf
2019-05-08 03:36
221k
48-Role-of-Immunotherapy-in-Post-Transplantation-Lymphoproliferative-Disorder...
2019-05-08 03:36
407k
49-Immunotherapy-and-polycythemia-vera.pdf
2019-05-08 03:36
282k
50-Immunotherapeutic-Approach-to-Laryngeal-Cancer.pdf
2019-05-08 03:36
582k
51-Immunotherapeutic-Approach-to-Oropharyngeal-Cancer.pdf
2019-05-08 03:36
511k
52-Immunotherapeutic-approach-to-nasopharyngeal-cancer.pdf
2019-05-08 03:36
238k
53-Application-of-molecular-targeted-therapy-for-refractory-metastatic-thyroi...
2019-05-08 03:36
295k
54-Immunotherapy-and-target-therapy-in-non-Hodgkins-lymphoma.pdf
2019-05-08 03:36
237k
55-Immunotherapy-in-basal-cell-carcinoma.pdf
2019-05-08 03:36
169k
56-Immunotherapy-for-cancers-of-the-biliary-tract.pdf
2019-05-08 03:36
270k
57-Immunotherapy-and-Uterine-Cancer.pdf
2019-05-08 03:36
256k
58-Immunotherapy-and-Acute-Lymphoblastic-Leukemia.pdf
2019-05-08 03:36
414k
59-Immunotherapy-and-myeliod-metaplasia.pdf
2019-05-08 03:36
125k
60-New-Targets-in-Treating-Multiple-Myeloma.pdf
2019-05-08 03:36
136k
61-Social-support-quality-of-life-and-mental-health-status-in-breast-cancer-p...
2019-05-08 03:36
245k
62-Immunotherapy-and-small-cell-lung-cancer-SCLC.pdf
2019-05-08 03:36
249k
63-Immunotherapy-and-squamous-cell-carcinoma.pdf
2019-05-08 03:36
235k
64-The-histogenesis-of-Ewing-Sarcoma.pdf
2019-05-08 03:36
189k
65-Immunotherapy-and-urinary-bladder-cancer.pdf
2019-05-08 03:36
236k
66-Propolis-gel-versus-benzydamine-in-preventing.pdf
2019-05-08 03:36
302k
67-Randomized-clinical-study-of-SCP-pacliataxel-in.pdf
2019-05-08 03:36
223k
68-Efficacy-and-safety-of-Specific-Conjugate-Particle-SCP.pdf
2019-05-08 03:36
275k
69-Efficacy-and-safety-of-Specific-Conjugate-Particle-SCP.pdf
2019-05-08 03:36
223k
Advances_and_Challenges_in_the_Development_of_an_Epstein-Barr_Virus_Vaccine.pdf
2024-04-10 03:41
180k
Cervical_2024.pdf
2025-02-26 02:40
502k
CMR-2-154.pdf
2019-12-30 06:21
575k
CMR-2-155.pdf
2019-12-30 06:21
508k
COVID-19_InterimGuidelines_Treatment_ENG.pdf
2020-03-31 05:02
339k
Generative_AI_Medical_Writing_Report.pdf
2025-02-04 06:11
312k
Global. Product List by Category. Pro, OTC, Clia.fra.xls
2019-10-23 07:51
37k
JBI-06-0046 (1).pdf
2025-02-27 09:22
492k
JBI-06-0046.pdf
2024-08-31 14:08
492k
JBI-06-0047.pdf
2024-10-01 02:06
871k
JGMCP-25.pdf
2025-04-02 03:07
523k
JMRCR-06-0061.pdf
2024-10-22 02:21
391k
JMRCR-07-0064.pdf
2025-01-29 03:16
758k
JMSS-06-0040.pdf
2024-10-18 12:23
523k
SCP tech_29Mar2020 (2).pptx
2020-04-06 05:10
1791k
Proudly Served by LiteSpeed Web Server at nexusalliancebiopharma.com Port 443